A cyclized compound of the amino acid sequence of formula X1 -GQRETPEGAEAKPWY-X2 wherein X1 comprises an amino acid (sequence) with 1 to 4, in particular 1 to 3 members, comprising natural or unnatural amino acids, in particular selected from the amino acid (sequence) C, KSP, K, ornithin, 4-amino butanoic acid, ß-alanine, and X2 comprises one amino acid, selected from natural amino acids, in particular selected from the group C, D, G and E, and wherein X comprises the N-terminal amino acid at ist first left position and X2 comprises the C-terminal amino acid at its last right position, optionally in the form of a salt for use in the treatment of inflammation, a pharmaceutical composition for treating inflammation comprising such compound and a method of treating inflammation comprising administering an effective amount of such compound to a mammal in need thereof.
